Pralidoxime Efficacy

Pralidoxime Efficacy is a quantitative measure within pharmacological research that denotes the capacity of pralidoxime to reactivate acetylcholinesterase inhibited by organophosphate compounds, thereby restoring enzymatic function and mitigating neurotoxic effects.

133

Publications

4.1K

Citations

428

Authors

168

Institutions

Publications per year

2017–2026

13

Authors

428

  1. KK
    Kamil Kuča

    University of Hradec Králové, Czechia

    27 publications · 1K citations

    19

    h-index

  2. GP
    Georg Petroianu

    United Arab Emirates University, United Arab Emirates

    16 publications · 482 citations

    14

    h-index

  3. SM
    Syed M. Nurulain

    United Arab Emirates University, United Arab Emirates

    11 publications · 323 citations

    10

    h-index

  4. JK
    Jiřı́ Kassa

    Jan Evangelista Purkyně Military Medical Academy, Czechia

    9 publications · 510 citations

    9

    h-index

  5. MY
    M. Y. Hasan

    United Arab Emirates University, United Arab Emirates

    8 publications · 201 citations

    8

    h-index

1–5 of 428

Venues

  1. Journal of Applied Toxicology

    14 publications · 465 citations

    11

    h-index

  2. PubMed

    Repository · 9 publications · 316 citations

    9

    h-index

  3. 5

    h-index

  4. JAMA

    5 publications · 227 citations

    5

    h-index

  5. Toxicology Letters

    4 publications · 53 citations

    4

    h-index

1–5